The Centers for Medicare & Medicaid Services today updated the Parts B and D drug spending dashboards with 2016 information. The dashboards provide pricing and utilization information for drugs covered under Medicare Parts B and D, including the total amount the program spent on a covered drug, how many beneficiaries used the drug, the cost per unit and the change in price from the prior year. Today’s update adds new fields, including the Average Sales Price, the number of manufacturers producing the drug, and what the drug is used to treat. This information is now available for all covered Part B and D drugs. The 2016 data show double-digit increases in spending per unit (i.e., price) for 876 Part D drugs and 145 Part B drugs, with 31 drugs increasing by more than 100%. CMS also released updated data on the prescription drugs prescribed by individual physicians and other providers paid under Medicare Part D.

Related News Articles

Headline
An analysis by KFF released last week found that in 2022, Medicare spent 27% ($2,585) more, on average, for individuals covered by Traditional Medicare after…
Headline
A House Dear Colleague letter calling on House leadership to address scheduled Medicaid Disproportionate Share Hospital payment cuts received signatures from…
Headline
The AHA Dec. 9 said it supports a potential Medicare $2 Drug List Model, where people enrolled in a Part D plan would have access to certain prescription drugs…
Headline
In comments Dec. 9 to the Medicare Payment Advisory Commission, the AHA shared its views on physician fee schedule payments, advanced alternative payment model…
Headline
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex…
Headline
The Centers for Medicare & Medicaid Services Nov. 26 proposed changes to the Medicare Advantage and prescription drug programs for contract year 2026.…